Abstract
The recent outbreak of swine-origin H1N1 influenza virus demonstrated the potential threat of new emerging human pathogenic influenza strains. Additionally, seasonal influenza virus strains cause substantial morbidity and mortality every year. Egg-derived influenza vaccines have served well to combat influenza infections since the 1940s. Still, faster and safer high-yielding production methods have to be established to meet the current needs for influenza vaccines. Insect cell-derived influenza vaccines are a new alternative to egg-derived vaccines. Three different approaches to insect cell-derived influenza vaccines have been established that could contribute to future influenza vaccine supply and development.
| Original language | English |
|---|---|
| Pages (from-to) | 313-320 |
| Number of pages | 8 |
| Journal | Trends in Molecular Medicine |
| Volume | 16 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2010 |
| Externally published | Yes |